Vendor Sheet
How a digital platform helps BioPharma laboratories achieve and maintain GxP compliance
The report explains how digital platforms help BioPharma laboratories achieve and maintain GxP compliance by strengthening data integrity, transparency, and record management throughout the product lifecycle. Regulatory agencies such as the FDA emphasize that data must be accurate, reliable, and traceable to ensure the safety, quality, and effectiveness of drugs, medical devices, and other regulated products. Data integrity issues remain a common finding during inspections, with many warning letters citing deficiencies in data governance, record retention, and documentation practices. These compliance failures can lead to financial, operational, and reputational risks. The report highlights how digital laboratory platforms address these challenges by centralizing data, automating workflows
